Background
Methods
Cells and culture
Treatment of cell cultures and inhibition of signalling enzymes
Inhibitor
|
Target
|
Concentration
|
Purchased from
|
---|---|---|---|
SB 203580 | p38 | 5 μM | Merck |
SP 600125 | JNK | 10 μM | A.G. Scientific |
Pifithrin | p53 | 10 μM | A.G. Scientific |
Pepstatin A | Cathepsin D, E | 5 μM | Calbiochem |
Ca-074 Me | Cathepsin B | 10 μM | SERVA Electrophoresis GmbH |
Cell viability assays
Flow cytometric analyses
Cytokeratin 18 cleavage assay
Immunocytochemistry and confocal microscopy
DNA binding assay for p53
Measurement of Thioredoxin
Statistical methods
Results and discussion
Selenite induced apoptosis and sarcomatoid cells were more sensitive
Epithelioid cells
|
Sarcomatoid cells
| |||||
---|---|---|---|---|---|---|
Inhibitor
|
Loss of δΦ
m
after selenite treatment
a
|
Statistical significance vs. no selenite
b
|
Statistical significance vs. selenite only
c
|
Loss of δΦ
m
after selenite treatment
a
|
Statistical significance vs. no selenite
b
|
Statistical significance vs. selenite only
c
|
Positive control | 2.89 (± 0.68) | 1.28 (± 0.18) | ||||
Selenite | 3.41 (± 0.57) | p < 0.01 | 3.30 (± 0.24) | p < 0.001 | ||
JNK | 0,94 (± 0.06) | 1.05 (± 0.05) | ||||
JNK + selenite | 3,96 (± 0.58) | p < 0.001 | ns | 3.74 (± 0.25) | p < 0.001 | ns |
p38 | 0.99 (± 0.04) | 0.88 (± 0.03) | ||||
p38 + selenite | 4.06 (± 0.63) | p < 0.001 | ns | 4.15 (± 0.52) | p < 0.001 | ns |
p53 | 0.74 (± 0.05) | 0.92 (± 0.03) | ||||
p53 + selenite | 2.62 (± 0.57) | p < 0.05 | ns | 3.59 (± 0.52) | p < 0.001 | ns |
Cathepsin B | 1.27 (± 0.12) | 1.46 (± 0.10) | ||||
Cathepsin B + selenite | 5.68 (± 0.70) | p < 0.001 | ns | 6.27 (± 0.75) | p < 0.001 | p < 0.01 |
Cathepsin D, E | 0.93 (± 0.06) | 0.90 (± 0.03) | ||||
Cathepsin D, E + selenite | 3.95 (± 0.77) | p < 0.001 | ns | 3.45 (± 0.37) | p < 0.001 | ns |